Scientific Frontline: Extended "At a Glance" Summary: Blood-Camouflaged Liquid Metal Nanoparticles
The Core Concept: A multifunctional nanoplatform using liquid metal nanoparticles coated in whole-blood components to deliver a three-pronged treatment against drug-resistant triple-negative breast cancer (TNBC).
Key Distinction/Mechanism: By using whole-blood components for camouflage, the nanoparticles evade immune clearance, allowing them to accumulate in tumors at five times the efficiency of conventional nanoparticles. Once there, they deploy three synchronized mechanisms: selective depletion of regulatory T cells (Tregs), heat-induced destruction of cancer cells via near-infrared laser activation, and the targeted release of an innate immune system activator.
Major Frameworks/Components:
- B-LM-DMX-αCD25 Nanoplatform: The core delivery system, utilizing gallium-based liquid metal.
- Photothermal Therapy: Gallium-based liquid metal nanoparticles boast a heat conversion efficiency exceeding 54%, allowing a near-infrared laser to heat tumors to 58°C in five minutes, triggering immunogenic cell death.
- Treg Depletion: Anti-CD25 antibodies on the nanoparticle surface target and eliminate immunosuppressive regulatory T cells.
- STING Pathway Activation: Laser activation triggers the release of the STING agonist DMX, which stimulates innate immunity by promoting dendritic cell maturation and driving tumor-specific cytotoxic T cell responses.
.jpg)



.png)



.jpg)


.jpg)



.png)
.jpg)
.jpg)
